254 related articles for article (PubMed ID: 36555198)
1. The universe of galectin-binding partners and their functions in health and disease.
Troncoso MF; Elola MT; Blidner AG; Sarrias L; Espelt MV; Rabinovich GA
J Biol Chem; 2023 Dec; 299(12):105400. PubMed ID: 37898403
[TBL] [Abstract][Full Text] [Related]
2. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival.
Elola MT; Wolfenstein-Todel C; Troncoso MF; Vasta GR; Rabinovich GA
Cell Mol Life Sci; 2007 Jul; 64(13):1679-700. PubMed ID: 17497244
[TBL] [Abstract][Full Text] [Related]
3. Galectin 7 leads to a relative reduction in CD4+ T cells, mediated by PD-1.
Wu G; Deng W; Chen HY; Cho HJ; Kim J
Sci Rep; 2024 Mar; 14(1):6625. PubMed ID: 38503797
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion.
Yıldırım C
Mol Biol Rep; 2024 Apr; 51(1):571. PubMed ID: 38662155
[TBL] [Abstract][Full Text] [Related]
5. Galectins in epithelial-mesenchymal transition: roles and mechanisms contributing to tissue repair, fibrosis and cancer metastasis.
Perez-Moreno E; Oyanadel C; de la Peña A; Hernández R; Pérez-Molina F; Metz C; González A; Soza A
Biol Res; 2024 Apr; 57(1):14. PubMed ID: 38570874
[TBL] [Abstract][Full Text] [Related]
6. Galectins in hematological malignancies.
St-Pierre Y
Am J Blood Res; 2011; 1(2):119-29. PubMed ID: 22432074
[TBL] [Abstract][Full Text] [Related]
7. Do galectins serve as soluble ligands for immune checkpoint receptors?
Torres NI; Baudou FG; Scheidegger MA; Dalotto-Moreno T; Rabinovich GA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38599662
[No Abstract] [Full Text] [Related]
8. Immunomodulation exerted by galectins: a land of opportunity in rare cancers.
Díaz-Alvarez L; López-Cortés GI; Pérez-Figueroa E
Front Immunol; 2023; 14():1301025. PubMed ID: 38022609
[TBL] [Abstract][Full Text] [Related]
9. KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells.
Zheng Y; Zhang H; Xiao C; Deng Z; Fan T; Zheng B; Li C; He J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586772
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.
Zheng T; Qian T; Zhou H; Cheng Z; Liu G; Huang C; Dou R; Liu F; You X
Aging (Albany NY); 2023 Jun; 15(12):5535-5549. PubMed ID: 37335105
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a monoclonal antibody that binds to Galectin-1.
Pfeffer K; Ho TH; Grill FJ; Ruiz Y; Lake DF
Protein Expr Purif; 2023 Oct; 210():106308. PubMed ID: 37209931
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Galectin-Binding Receptors on B Cells.
Chakraborty A; Mohammed NBB; Bernasconi AE; Dimitroff CJ
Methods Mol Biol; 2022; 2442():565-580. PubMed ID: 35320546
[TBL] [Abstract][Full Text] [Related]
13. Galectins and their ligands: negative regulators of anti-tumor immunity.
Cedeno-Laurent F; Dimitroff CJ
Glycoconj J; 2012 Dec; 29(8-9):619-25. PubMed ID: 22544342
[TBL] [Abstract][Full Text] [Related]
14. Role of Galectins in Tumors and in Clinical Immunotherapy.
Chou FC; Chen HY; Kuo CC; Sytwu HK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389859
[TBL] [Abstract][Full Text] [Related]
15. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
16. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.
Lau LS; Mohammed NBB; Dimitroff CJ
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555198
[TBL] [Abstract][Full Text] [Related]
17. Engineering galectin-glycan interactions for immunotherapy and immunomodulation.
Farhadi SA; Hudalla GA
Exp Biol Med (Maywood); 2016 May; 241(10):1074-83. PubMed ID: 27229902
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
